Gurlek, F. and Tasdemir, E. 2020. Is it an advantage or disadvantage to usage angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in COVID-19 patients?. International Journal of Research in Medical Sciences. 8, 12 (Nov. 2020), 4200–4205. DOI:https://doi.org/10.18203/2320-6012.ijrms20205289.